Expression of the gastrin-releasing-peptide receptor (GRP-R) is correlated with lymphatic vessel invasion in intestinal adenocarcinomas.

被引：0
|
作者：
Saurin, JC
Rouault, JP
Abello, J
Remy, L
Berger, F
Chayvialle, JA
机构：
[1] HOP EDOUARD HERRIOT, INSERM U45, LYON, FRANCE
[2] HOP EDOUARD HERRIOT, MOL BIOL LAB, LYON, FRANCE
[3] HOP EDOUARD HERRIOT, SERV ANAT PATHOL, LYON, FRANCE
来源：
GASTROENTEROLOGY | 1997年 / 112卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A1185 / A1185
页数：1
相关论文
共 40 条
  • [31] An aspartate residue in transmembrane domain II (TMII) and an arginine residue in transmembrane domain VII (TMVII) of the gastrin-releasing peptide receptor (GRP-R) interact to facilitate heterotrimeric G protein coupling
    Donohue, PJ
    Sainz, E
    Akeson, M
    Kroog, GS
    Mantey, SA
    Battey, JF
    Jensen, RT
    Northup, JK
    MOLECULAR BIOLOGY OF THE CELL, 1999, 10 : 418A - 418A
  • [32] 68Ga-Radiolabeling and Pharmacological Characterization of a Kit-Based Formulation of the Gastrin-Releasing Peptide Receptor (GRP-R) Antagonist RM2 for Convenient Preparation of [68Ga]Ga-RM2
    Chastel, Adrien
    Vimont, Delphine
    Claverol, Stephane
    Zerna, Marion
    Bodin, Sacha
    Berndt, Mathias
    Chaignepain, Stephane
    Hindie, Elif
    Morgat, Clement
    PHARMACEUTICS, 2021, 13 (08)
  • [33] 68Ga-radiolabeling and pharmacological characterization of a kit-based formulation of the Gastrin-Releasing Peptide Receptor (GRP-R) antagonist RM2 for convenient preparation of [68Ga]Ga-RM2
    Morgat, C.
    Chastel, A.
    Vimont, D.
    Claverol, S.
    Berndt, M.
    Zerna, M.
    Chaignepain, S.
    Hindie, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S409 - S409
  • [34] Co-expression of gastrin-releasing peptide (GRP) and receptor (GRPR) is associated with formation of villi during development of the mouse and human GI tract.
    Carroll, RE
    Matkowskyj, KA
    Sekosan, M
    Scaunas, D
    McDonald, T
    Benya, RV
    GASTROENTEROLOGY, 1999, 116 (04) : A969 - A969
  • [35] In vitro and in vivo evaluation of 111In-labeled DOTA-8-Aoc-BBN[7-14]NH2 conjugate for specific targeting of tumors expressing gastrin releasing peptide receptors (GRP-R).
    Gali, H
    Hoffman, TJ
    Owen, NK
    Sieckman, GL
    Volkert, WA
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 119P - 119P
  • [36] Targeted radiotherapy of gastrin-releasing-peptide (GRP) receptor expressing prostate cancer:: Therapeutic efficacy of 213Bi vs. 177Lu labeled DOTAPEG4Bombesin (7-14) (DOTA-PESIN)
    Wild, D.
    Frischknecht, M.
    Good, S.
    Zhang, H.
    Morgenstern, A.
    Bruchertseifer, F.
    Kneifel, S.
    Boisclair, J.
    Provencher-Bolliger, A.
    Maecke, H. R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S240 - S240
  • [37] Targeted radiotherapy of Gastrin-Releasing-Peptide (GRP) receptor expressing prostate cancer:: therapeutic efficacy of 213Bi vs. 177Lu labeled DOTA-PEG4-Bombesin (7-14) (DOTA-PESIN)
    Wild, D.
    Good, S.
    Frischknecht, M.
    Zhang, H.
    Morgenstern, A.
    Bruchertseifer, F.
    Kneifel, S.
    Boisclair, J.
    Provencher-Bolliger, A.
    Maecke, H. R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S378 - S378
  • [38] Targeted radiotherapy of Gastrin-Releasing-Peptide (GRP) receptor expressing prostate cancer:: therapeutic efficacy of 213Bi vs. 177Lu labeled DOTA-PEG4-Bombesin (7-14) (DOTA-PESIN)
    Wild, D.
    Good, S.
    Frischknecht, M.
    Zhang, H.
    Morgenstern, A.
    Bruchertseifer, F.
    Kneifel, S.
    Boisclair, J.
    Provencher-Bolliger, A.
    Maecke, H. R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S183 - S183
  • [39] Increased gastrin-releasing peptide (GRP) receptor expression in tumour cells confers sensitivity to [Arg6,D-Trp7,9,NmePhe8]-substance P (6–11)-induced growth inhibition
    C M Waters
    A C MacKinnon
    J Cummings
    U Tufail-Hanif
    D Jodrell
    C Haslett
    T Sethi
    British Journal of Cancer, 2003, 88 : 1808 - 1816
  • [40] Increased gastrin-releasing peptide (GRP) receptor expression in tumour cells confers sensitivity to [Arg6,D-Trp7,9,NmePhe8]-substance P (6-11)-induced growth inhibition
    Waters, CM
    MacKinnon, AC
    Cummings, J
    Tufail-Hanif, U
    Jodrell, D
    Haslett, C
    Sethi, T
    BRITISH JOURNAL OF CANCER, 2003, 88 (11) : 1808 - 1816
1234